Cme (CME) Net Income towards Common Stockholders (2009 - 2026)

Cme (CME) has 18 years of Net Income towards Common Stockholders data on file, last reported at $1.2 billion in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 23.7% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 billion (up 18.53% YoY) and the FY2025 annual result came in at $4.0 billion, up 15.5% from the prior year.
• Net Income towards Common Stockholders steadied at $1.2 billion in Q1 2026 per CME's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $1.2 billion in Q4 2025 and bottomed at $630.0 million in Q4 2022.
• The 5-year median for Net Income towards Common Stockholders is $863.7 million (2024), against an average of $853.7 million.
• The widest annual swing landed in 2022, when Net Income towards Common Stockholders declined 27.57%; it then jumped 35.23% in 2025.
• Tracing CME's Net Income towards Common Stockholders over 5 years: stood at $630.0 million in 2022, then rose by 27.67% to $804.3 million in 2023, then gained by 7.39% to $863.7 million in 2024, then jumped by 35.23% to $1.2 billion in 2025, then changed by 0.0% to $1.2 billion in 2026.
• Per Business Quant, the three latest CME Net Income towards Common Stockholders figures stand at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $896.6 million (Q3 2025).

Peer Comparison